OOjer Pharma — Seed (estimated) · €640K
A €640,000 round from existing shareholders and new investors. It includes a €100,000 convertible loan from Sodena. The money funds sales of Lipovir® and Impetine® after their first marketing approvals, plus further product development.
Lead unknown
RoundSeed (estimated)
Announced31 May 2019
CityPamplona
SectorHealthtech & Bio · Biotech / Dermatology pharma
Source
W
W
